Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The FDA has granted quick monitor designation to the investigational drug CRB-701 for recurrent or metastatic head and neck squamous cell carcinomaThe U.S....
Anemia and gastrointestinal bleeding are among the many most typical signs for sufferers with gastrointestinal stromal tumors (GIST), defined Dr. Rosario Ligresti, chief...
